Manning & Napier Advisors LLC Astrazeneca PLC Transaction History
Manning & Napier Advisors LLC
- $8.85 Trillion
- Q2 2024
A detailed history of Manning & Napier Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 2,416,672 shares of AZN stock, worth $189 Million. This represents 2.13% of its overall portfolio holdings.
Number of Shares
2,416,672Holding current value
$189 Million% of portfolio
2.13%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,332Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.08 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.33 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.18 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.87 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.38 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $243B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...